{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:32:27Z","timestamp":1781008347854,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2020QNB045"],"award-info":[{"award-number":["2020QNB045"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018623","name":"Quanzhou City Science and Technology Program","doi-asserted-by":"publisher","award":["2020C026R"],"award-info":[{"award-number":["2020C026R"]}],"id":[{"id":"10.13039\/501100018623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pathogenic <jats:italic>PAK1<\/jats:italic> variants were described to be causative of neurodevelopmental disorder with macrocephaly, seizures, and speech delay. Herein, we present a de novo<jats:italic> PAK1<\/jats:italic> variant combine with a de novo terminal 1q microdeletion in a Chinese pediatric patient, aiming to provide more insights into the underlying genotype\u2013phenotype relationship.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Enrolled in this study was a 6-year-old girl with clinical features of global developmental delay, severe intellectual disability, speech delay, and seizures from Quanzhou region of China. Karyotype and chromosomal microarray analysis (CMA) were performed to detect chromosome abnormalities in this family. Whole exome sequencing (WES) was performed to investigate additional genetic variants in this family.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>No chromosomal abnormalities were elicited from the entire family by karyotype analysis. Further familial CMA results revealed that the patient had a de novo 2.7-Mb microdeletion (arr[GRCh37] 1q44(246,454,321_249,224,684)\u2009\u00d7\u20091]) in 1q44 region, which contains 14 OMIM genes, but did not overlap the reported smallest region of overlap (SRO) responsible for the clinical features in 1q43q44 deletion syndrome. In addition, WES result demonstrated a de novo NM_002576: c.251C\u2009&gt;\u2009G (p.T84R) variant in <jats:italic>PAK1<\/jats:italic> gene in the patient, which was interpreted as a likely pathogenic variant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this study, we identify a novel <jats:italic>PAK1<\/jats:italic> variant associated with a terminal 1q microdeletion in a patient with neurodevelopmental disorder. In addition, we believe that the main clinical features may ascribe to the pathogenic variant in <jats:italic>PAK1<\/jats:italic> gene in the patient.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01433-x","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T15:05:22Z","timestamp":1673276722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures"],"prefix":"10.1186","volume":"16","author":[{"given":"Jianlong","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoxiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunnuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"issue":"Pt 2","key":"1433_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BJ20041638","volume":"386","author":"ZS Zhao","year":"2005","unstructured":"Zhao ZS, Manser E. PAK and other Rho-associated kinases\u2014effectors with surprisingly diverse mechanisms of regulation. Biochem J. 2005;386(Pt 2):201\u201314.","journal-title":"Biochem J"},{"issue":"8","key":"1433_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.tibs.2008.06.002","volume":"33","author":"J Eswaran","year":"2008","unstructured":"Eswaran J, Soundararajan M, Kumar R, Knapp S. UnPAKing the class differences among p21-activated kinases. Trends Biochem Sci. 2008;33(8):394\u2013403.","journal-title":"Trends Biochem Sci"},{"key":"1433_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.gene.2016.12.014","volume":"605","author":"R Kumar","year":"2017","unstructured":"Kumar R, Sanawar R, Li X, Li F. Structure, biochemistry, and biology of PAK kinases. Gene. 2017;605:20\u201331.","journal-title":"Gene"},{"issue":"1","key":"1433_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/1675","volume":"20","author":"KM Allen","year":"1998","unstructured":"Allen KM, Gleeson JG, Bagrodia S, et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet. 1998;20(1):25\u201330.","journal-title":"Nat Genet"},{"key":"1433_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcancer.2018.01.006","volume":"54","author":"CK Rane","year":"2019","unstructured":"Rane CK, Minden A. P21 activated kinase signaling in cancer. Semin Cancer Biol. 2019;54:40\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"1433_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajhg.2018.09.005","volume":"103","author":"FL Harms","year":"2018","unstructured":"Harms FL, Kloth K, Bley A, et al. Activating mutations in PAK1, encoding p21-activated kinase 1, cause a neurodevelopmental disorder. Am J Hum Genet. 2018;103(4):579\u201391.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1433_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ajmg.a.30695","volume":"135","author":"Y van Bever","year":"2005","unstructured":"van Bever Y, Rooms L, Laridon A, et al. Clinical report of a pure subtelomeric 1qter deletion in a boy with mental retardation and multiple anomalies adds further evidence for a specific phenotype. Am J Med Genet A. 2005;135(1):91\u20135.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"1433_CR8","first-page":"167","volume":"35","author":"DM Ioan","year":"1992","unstructured":"Ioan DM, Maximilian C, Kleczkowska A, Fryns JP. Distal deletion of the long arm of chromosome number 1 (q43\u2013>qter) associated with severe mental retardation and a nonspecific dysmorphic syndrome. Ann Genet. 1992;35(3):167\u20139.","journal-title":"Ann Genet"},{"issue":"6","key":"1433_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ajmg.a.31611","volume":"143A","author":"JL Merritt 2nd","year":"2007","unstructured":"Merritt JL 2nd, Zou Y, Jalal SM, Michels VV. Delineation of the cryptic 1qter deletion phenotype. Am J Med Genet A. 2007;143A(6):599\u2013603.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"1433_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ejhg.2011.171","volume":"20","author":"SC Nagamani","year":"2012","unstructured":"Nagamani SC, Erez A, Bay C, et al. Delineation of a deletion region critical for corpus callosal abnormalities in chromosome 1q43-q44. Eur J Hum Genet. 2012;20(2):176\u20139.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1433_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00439-011-1073-y","volume":"131","author":"BC Ballif","year":"2012","unstructured":"Ballif BC, Rosenfeld JA, Traylor R, et al. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44. Hum Genet. 2012;131(1):145\u201356.","journal-title":"Hum Genet"},{"issue":"7","key":"1433_CR12","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/ajmg.a.35423","volume":"158A","author":"G Thierry","year":"2012","unstructured":"Thierry G, B\u00e9n\u00e9teau C, Pichon O, et al. Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures. Am J Med Genet A. 2012;158A(7):1633\u201340.","journal-title":"Am J Med Genet A"},{"key":"1433_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13039-019-0461-1","volume":"12","author":"J Zhuang","year":"2019","unstructured":"Zhuang J, Wang Y, Zeng S, Lv C, Lin Y, Jiang Y. A prenatal diagnosis and genetics study of five pedigrees in the Chinese population with Xp22.31 microduplication. Mol Cytogenet. 2019;12:50.","journal-title":"Mol Cytogenet"},{"issue":"1","key":"1433_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13039-021-00568-9","volume":"14","author":"J Zhuang","year":"2021","unstructured":"Zhuang J, Zhang N, Fu W, et al. Cytogenetic and molecular analysis of distal 4q duplication with distinctive phenotype using single-nucleotide polymorphism array. Mol Cytogenet. 2021;14(1):46.","journal-title":"Mol Cytogenet"},{"issue":"2","key":"1433_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) [published correction appears in Genet Med. 2021 Nov;23(11):2230]. Genet Med. 2020;22(2):245\u201357.","journal-title":"Genet Med"},{"key":"1433_CR16","doi-asserted-by":"publisher","first-page":"816090","DOI":"10.3389\/fped.2022.816090","volume":"10","author":"J Zhuang","year":"2022","unstructured":"Zhuang J, Chen C, Chen Y, et al. Identification of a rare variant of c.1777G>A (p.G593S) in the COL1A1 gene as the etiology of recurrent osteogenesis imperfecta by whole-exome sequencing. Front Pediatr. 2022;10:816090.","journal-title":"Front Pediatr"},{"issue":"5","key":"1433_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"6","key":"1433_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3345\/kjp.2014.57.6.292","volume":"57","author":"JH Cho","year":"2014","unstructured":"Cho JH, Song ES, Kim HN, Oh BS, Choi YY. A chromosome 1q44 deletion in a 4-month-old girl; the first report in Korea. Korean J Pediatr. 2014;57(6):292\u20136.","journal-title":"Korean J Pediatr"},{"key":"1433_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.gene.2017.03.025","volume":"616","author":"DS Westphal","year":"2017","unstructured":"Westphal DS, Andres S, Beitzel KI, Makowski C, Meitinger T, Hoefele J. Identification of a de novo microdeletion 1q44 in a patient with hypogenesis of the corpus callosum, seizures and microcephaly\u2014a case report. Gene. 2017;616:41\u20134.","journal-title":"Gene"},{"key":"1433_CR20","doi-asserted-by":"publisher","first-page":"648351","DOI":"10.3389\/fgene.2021.648351","volume":"12","author":"Y Tung","year":"2021","unstructured":"Tung Y, Lu H, Lin W, et al. Case report: identification of a de novo microdeletion 1q44 in a patient with seizures and developmental delay. Front Genet. 2021;12:648351.","journal-title":"Front Genet"},{"issue":"4","key":"1433_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejmg.2010.04.001","volume":"53","author":"A Caliebe","year":"2010","unstructured":"Caliebe A, Kroes HY, van der Smagt JJ, et al. Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene. Eur J Med Genet. 2010;53(4):179\u201385.","journal-title":"Eur J Med Genet"},{"issue":"4","key":"1433_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/ajmg.a.38139","volume":"173","author":"N Raun","year":"2017","unstructured":"Raun N, Mailo J, Spinelli E, et al. Quantitative phenotypic and network analysis of 1q44 microdeletion for microcephaly. Am J Med Genet A. 2017;173(4):972\u20137.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"1433_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ejmg.2012.08.005","volume":"55","author":"KK Selmer","year":"2012","unstructured":"Selmer KK, Bryne E, R\u00f8dningen OK, Fannemel M. A de novo 163 kb interstitial 1q44 microdeletion in a boy with thin corpus callosum, psychomotor delay and seizures. Eur J Med Genet. 2012;55(12):715\u20138.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"1433_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ajmg.a.36198","volume":"164A","author":"R Gupta","year":"2014","unstructured":"Gupta R, Agarwal M, Boqqula VR, Phadke RV, Phadke SR. Hemiconvulsion-hemiplegia-epilepsy syndrome with 1q44 microdeletion: causal or chance association. Am J Med Genet A. 2014;164A(1):186\u20139.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"1433_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/ajmg.a.35779","volume":"161A","author":"SJ Perlman","year":"2013","unstructured":"Perlman SJ, Kulkarni S, Manwaring L, Shinawi M. Haploinsufficiency of ZNF238 is associated with corpus callosum abnormalities in 1q44 deletions. Am J Med Genet A. 2013;161A(4):711\u20136.","journal-title":"Am J Med Genet A"},{"key":"1433_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-4939-8889-1_13","volume":"1885","author":"M Ganapathi","year":"2019","unstructured":"Ganapathi M, Nahum O, Levy B. Prenatal diagnosis using chromosomal SNP microarrays. Methods Mol Biol. 2019;1885:187\u2013205.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"1433_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","volume":"86","author":"DT Miller","year":"2010","unstructured":"Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749\u201364.","journal-title":"Am J Hum Genet"},{"key":"1433_CR28","doi-asserted-by":"publisher","first-page":"798607","DOI":"10.3389\/fgene.2022.798607","volume":"13","author":"P Granata","year":"2022","unstructured":"Granata P, Cocciadiferro D, Zito A, et al. Whole exome sequencing in 16p13.11 microdeletion patients reveals new variants through deductive and systems medicine approaches. Front Genet. 2022;13:798607.","journal-title":"Front Genet"},{"issue":"2","key":"1433_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejmg.2018.06.010","volume":"62","author":"Y Qiao","year":"2019","unstructured":"Qiao Y, Bagheri H, Tang F, et al. Exome sequencing identified a de novo mutation of PURA gene in a patient with familial Xp22.31 microduplication. Eur J Med Genet. 2019;62(2):103\u20138.","journal-title":"Eur J Med Genet"},{"issue":"11","key":"1433_CR30","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/brain\/awz264","volume":"142","author":"S Horn","year":"2019","unstructured":"Horn S, Au M, Basel-Salmon L, et al. De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures. Brain. 2019;142(11):3351\u20139.","journal-title":"Brain"},{"issue":"3","key":"1433_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1128\/MCB.00969-10","volume":"31","author":"W Huang","year":"2011","unstructured":"Huang W, Zhou Z, Asrar S, Henkelman M, Xie W, Jia Z. p21-Activated kinases 1 and 3 control brain size through coordinating neuronal complexity and synaptic properties. Mol Cell Biol. 2011;31(3):388\u2013403.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1433_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s10038-020-0728-8","volume":"65","author":"S Ohori","year":"2020","unstructured":"Ohori S, Mitsuhashi S, Ben-Haim R, et al. A novel PAK1 variant causative of neurodevelopmental disorder with postnatal macrocephaly. J Hum Genet. 2020;65(5):481\u20135.","journal-title":"J Hum Genet"},{"issue":"7504","key":"1433_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nature13320","volume":"510","author":"PK Mazur","year":"2014","unstructured":"Mazur PK, Reynoird N, Khatri P, et al. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature. 2014;510(7504):283\u20137.","journal-title":"Nature"},{"issue":"9","key":"1433_CR34","first-page":"9765","volume":"10","author":"F Wang","year":"2017","unstructured":"Wang F, Qi J, Yu T, et al. Novel karyotypes of partial monosomy 21 and partial monosomy 1 and underlying etiology. Int J Clin Exp Pathol. 2017;10(9):9765\u201373.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01433-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01433-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01433-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T15:10:42Z","timestamp":1673277042000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01433-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01433-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics Committee approval was obtained from the Institutional Ethics Committee of Quanzhou Women\u2019s and Children\u2019s Hospital for the commencement of this study (2020No.31). We received informed consent from the study participants, and they agreed to the publication of a report on the study. All procedures performed involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that written informed consent was signed by the patient\u2019s parents for publishing their own and their children\u2019s genetic data and relevant information, and the written informed consent is available for request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}